Adnan Alseidi, MD, EdM

Professor
University of California, San Francisco

Poster(s):

• E192: Re-evaluating the Role of Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival

• E204: Stage-for-Stage Survival is Equivalent After Multiagent Neoadjuvant Therapy Compared to Upfront Surgery Followed by Multiagent Adjuvant Chemotherapy in Over 2900 Patients with Pancreatic Cancer

• E223: Vascular Involvement in Pancreas Cancer: Limitations of Relying on Imaging and Expert Opinion

• E338: An Explainable Machine Learning Framework for Predicting Textbook Outcome After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy